China Resources Medical Holdings Co. Ltd. released its interim report for 2025, revealing a total revenue of RMB4,524.8 million, marking a period-over-period decline of 9.1% compared to the previous year. The hospital business segment, a significant contributor to the company's operations, experienced a revenue decrease of 7.4%, amounting to RMB4,259 million. The gross profit for this segment was RMB670 million, down 27.4% from the previous period, with a gross profit margin of 15.7%. The management discussion highlighted that JR Holdings and JR Renkang contributed a combined revenue of RMB231 million, with a net profit of RMB97 million, of which RMB47.77 million was attributable to the Group. The company noted a decline in revenue per visit in its hospital business, with out-patient and emergency visits increasing by 1.0% while in-patient visits fell by 3.9%. The Group is focusing on improving quality and efficiency to mitigate the impact of reduced revenue per visit on profits. The Jing Mei Hospital Group, recognized as a leading hospital in the Mentougou district and an important medical institution in Beijing's western region, maintained stable profitability and satisfactory operational performance. The Group intends to continue leveraging its investment in JR Holdings and JR Renkang, as well as its cooperation with the Jing Mei Group, to adapt to changing market conditions.